260 related articles for article (PubMed ID: 11714886)
1. A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
Jackson EK; Kost CK; Herzer WA; Smits GJ; Tofovic SP
J Pharmacol Exp Ther; 2001 Dec; 299(3):978-87. PubMed ID: 11714886
[TBL] [Abstract][Full Text] [Related]
2. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
Gellai M; Schreiner GF; Ruffolo RR; Fletcher T; DeWolf R; Brooks DP
J Pharmacol Exp Ther; 1998 Sep; 286(3):1191-6. PubMed ID: 9732378
[TBL] [Abstract][Full Text] [Related]
3. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
[TBL] [Abstract][Full Text] [Related]
4. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
5. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
[TBL] [Abstract][Full Text] [Related]
6. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
[TBL] [Abstract][Full Text] [Related]
7. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
Petersen JS; Shalmi M; Lam HR; Christensen S
J Pharmacol Exp Ther; 1991 Jul; 258(1):1-7. PubMed ID: 2072287
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
9. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
Schnackenberg CG; Merz E; Brooks DP
Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis.
Jonassen TE; Petersen JS; Sørensen AM; Andreasen F; Christensen S
J Pharmacol Exp Ther; 1998 Dec; 287(3):931-6. PubMed ID: 9864275
[TBL] [Abstract][Full Text] [Related]
11. Effects of renal denervation on sodium balance and renal function during chronic furosemide administration in rats.
Petersen JS; DiBona GF
J Pharmacol Exp Ther; 1992 Sep; 262(3):1103-9. PubMed ID: 1527716
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
[TBL] [Abstract][Full Text] [Related]
13. [Effect of furosemide on the intrarenal hemodynamics and excretory renal function depending on salt regime].
Zhidomorov NIu; Shtrygol' SIu
Eksp Klin Farmakol; 2002; 65(3):22-4. PubMed ID: 12227089
[TBL] [Abstract][Full Text] [Related]
14. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
15. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
16. Effects of saponins from Herniaria glabra on blood pressure and renal function in spontaneously hypertensive rats.
Rhiouani H; Settaf A; Lyoussi B; Cherrah Y; Lacaille-Dubois MA; Hassar M
Therapie; 1999; 54(6):735-9. PubMed ID: 10709449
[TBL] [Abstract][Full Text] [Related]
17. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
18. Diuretic response to adenosine A(1) receptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins.
Kost CK; Herzer WA; Rominski BR; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2000 Feb; 292(2):752-60. PubMed ID: 10640315
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the diuretic and natriuretic effect of furosemide by the calcium antagonist nifedipine.
Piryova B; Girchev R
Acta Physiol Pharmacol Bulg; 1989; 15(1):13-8. PubMed ID: 2773646
[TBL] [Abstract][Full Text] [Related]
20. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
